Ten63 Therapeutics

Biotechnology ResearchNorth Carolina, United States11-50 Employees

Ten63 Therapeutics is a biotechnology research company focused on developing durable therapeutics for cancer and other lethal diseases. It aims to create treatments that can achieve lasting responses by predicting and overcoming drug resistance, using its BEYOND in silico platform to generate novel therapeutics that target previously undruggable areas. The firm emphasizes collaboration and diverse thinking, prioritizing a workforce that values teamwork and determination in tackling challenging scientific problems. Based in Durham, North Carolina, United States, the company operates with a relatively small, specialized team and is advancing its work within the broader biopharma ecosystem.

Ten63 Therapeutics positions itself at the intersection of computational methods and physics-based modeling to inform early drug design. The organization engages in collaborations and partnerships within the industry to explore multi-target approaches and broaden the potential impact of its therapeutics, including activities announced in recent years and described in its public disclosures. The company’s focus covers oncology and other severe diseases, with a stated aim of delivering more effective and durable medical interventions for patients.

Sign up for free to view info

Email Format Employee directory